On Wednesday, Dover Corporation (NYSE:DOV)’s shares surged 4.34% to $73.99.
Dover Corporation, declared that it has revised its forecast for 2015 full-year revenue and diluted earnings per share from ongoing operations (“EPS”). Highlights includes:
- Anticipates full-year revenue to decline -4% to -6%, counting organic revenue of -2% to -4%, a -4% influence from foreign currencies, and growth from acquisitions of 2%
- Forecasts full-year diluted earnings per share from ongoing operations to be in the range of $4.20 to $4.40.
Dover Corporation manufactures and sells a range of equipment and components, specialty systems, and support services in the United States. The company operates in four segments: Energy, Engineered Systems, Fluids, and Refrigeration & Food Equipment.
Zillow Group, Inc. (NASDAQ:Z)’s shares gained 4.33% to $95.62, during the last trading session on Wednesday.
Zillow Group, hosted a conference call Tuesday, April 14 and talked about an operational progress report related to the company’s acquisition of Trulia, which closed on February 17, 2015. As part of the call, the company talked about its preliminary full-year pro forma outlook for 2015.
Zillow Group, Inc. operates real estate and home-related information marketplaces on mobile and the Web in the United States. It offers a portfolio of brands and products to assist people find vital information about homes, and connect with local professionals.
At the end of Wednesday’s trade, Exact Sciences Corporation (NASDAQ:EXAS)’s shares gained 4.26% to $24.24.
Exact Sciences Corporation, declared expanded patient access to Cologuard as a result of several insurers now covering the test. Cologuard is now covered for more than 90 million Medicare and commercial lives across the U.S.
Since the start of 2015, several insurers began covering Cologuard as a noninvasive colon cancer screening test. In addition to several smaller regional providers, insurance plans covering the test now comprise:
- Anthem Blue Cross and Blue Shield, a leading national health plan with more than 37 million members across 14 states,
- Tufts Health Plan, with more than 1 million members across Massachusetts and Rhode Island and ranked the number one health plan for quality in the country for its Commercial plans and its Medicaid plans*,
- CareFirst BlueCross BlueShield PPO (CareFirst), with 2.3 million eligible members across Maryland, District of Columbia and Northern Virginia,
- Excellus BCBS WNY, with more than 1.4 million members across Western New York and
- Dean Health Plan, insuring more than 272,037 members across Central Wisconsin.
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing non-invasive colorectal cancer screening products. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer.
Finally, Intel Corporation (NASDAQ:INTC), ended its Wednesday’s trading session with 4.26% gain, and closed at $32.83.
Wind River, a wholly owned partner of Intel® Corporation, declared it was named among the ‘Best Places to Work 2015’ by the San Francisco Business Times and Silicon Valley Business Journal. Wind River was recognized based on employee satisfaction across several areas, counting career growth, workplace environment, and company administration.
“Wind River is driven by a core set of values to create an exceptional culture; one that fosters innovation and collaboration, enables employees to grow in their career, and empowers them to drive exceptional results for our customers,” said Barry Mainz, president of Wind River. “It is an honor to receive this distinction, and there is no greater reward than having Wind River voted a ‘best place to work’ by our employees.”
Intel Corporation designs, manufactures, and sells integrated digital technology platforms worldwide. It operates through PC Client Group, Data Center Group, Internet of Things Group, Mobile and Communications Group, Software and Services, and All Other segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
